ACLARION, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2018-05-15: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2017-07-27; Total offering amount $4,000,000.
- 2017-08-11: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2017-07-27; Total offering amount $2,999,999.
- 2015-03-03: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-02-18; Total offering amount $5,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2018-05-15 D/A | Rule 506(b) | Equity | 2017-07-27 | $4,000,000 | $3,258,099 | $741,901 | 14 |
| 2017-08-11 | Rule 506(b) | Equity | 2017-07-27 | $2,999,999 | $1,499,999 | $1,500,000 | 1 |
| 2015-03-03 | Rule 506(b) | Equity | 2015-02-18 | $5,000,000 | $2,023,736 | $2,976,264 | 1 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |